4.6 Article

SLC6A8 is a Potential Biomarker for Poor Prognosis in Lung Adenocarcinoma

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Oncology

Lung cancer LDCT screening and mortality reduction - evidence, pitfalls and future perspectives

Matthijs Oudkerk et al.

Summary: Despite being the leading cause of cancer-related mortality worldwide, lung cancer mortality has been reduced through LDCT screening in high-risk populations. Screening programs have been implemented in the USA and are currently underway in the UK, with a framework called SPIRAL to define future research scope.

NATURE REVIEWS CLINICAL ONCOLOGY (2021)

Article Oncology

Cancer Statistics, 2021

Rebecca L. Siegel et al.

Summary: Every year, the American Cancer Society projects the numbers of new cancer cases and deaths in the United States, with the latest data showing a significant decline in lung cancer mortality, while prostate cancer mortality has plateaued and breast and colorectal cancer mortality have slowed. Improvements in treatment have accelerated progress against lung cancer, leading to a record drop in overall cancer mortality.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Oncology

SLC6A8 is involved in the progression of non-small cell lung cancer through the Notch signaling pathway

Yan Feng et al.

Summary: SLC6A8 is highly expressed in NSCLC and associated with poor prognosis. It promotes proliferation, migration, and invasion in NSCLC by activating the Notch signaling pathway.

ANNALS OF TRANSLATIONAL MEDICINE (2021)

Article Multidisciplinary Sciences

Therapeutic targeting of SLC6A8 creatine transporter suppresses colon cancer progression and modulates human creatine levels

Isabel Kurth et al.

Summary: The study demonstrates that RGX-202 inhibits creatine import, reduces intracellular phosphocreatine and ATP levels, and induces tumor apoptosis, showing inhibitory effects on colorectal cancer growth across various mutational backgrounds. Combining RGX-202 with other drugs can cause regressions of colorectal cancer tumors, and perturbs creatine metabolism in patients with metastatic CRC in a clinical trial.

SCIENCE ADVANCES (2021)

Article Oncology

SLC6A8-mediated intracellular creatine accumulation enhances hypoxic breast cancer cell survival via ameliorating oxidative stress

Qiao Li et al.

Summary: The study demonstrates that SLC6A8-mediated creatine accumulation plays a crucial role in promoting TNBC progression and may offer a potential therapeutic strategy for treating TNBC with high SLC6A8 expression.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)

Article Medicine, Research & Experimental

m6A regulator-based methylation modification patterns characterized by distinct tumor microenvironment immune profiles in colon cancer

Wei Chong et al.

Summary: Recent studies have shown that m(6)A modification is significantly associated with TME diversity, and different m(6)A modification patterns in colon cancer are correlated with distinct clinical outcomes and biological pathways.

THERANOSTICS (2021)

Article Cell Biology

Extracellular vesicles as biomarkers and therapeutic targets for cancer

Fumihiko Urabe et al.

AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2020)

Article Biochemical Research Methods

TISIDB: an integrated repository portal for tumor-immune system interactions

Beibei Ru et al.

BIOINFORMATICS (2019)

Article Oncology

Long-Term Follow-Up of Ground-Glass Nodules After 5 Years of Stability

Hyun Woo Lee et al.

JOURNAL OF THORACIC ONCOLOGY (2019)

Article Immunology

Creatine uptake regulates CD8 T cell antitumor immunity

Stefano Di Biase et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2019)

Review Biochemistry & Molecular Biology

Understanding the tumor immune microenvironment (TIME) for effective therapy

Mikhail Binnewies et al.

NATURE MEDICINE (2018)

Review Biochemistry & Molecular Biology

Understanding the Intersections between Metabolism and Cancer Biology

Matthew G. Vander Heiden et al.

Review Biochemistry & Molecular Biology

Reprogramming of glucose, fatty acid and amino acid metabolism for cancer progression

Zhaoyong Li et al.

CELLULAR AND MOLECULAR LIFE SCIENCES (2016)

Review Cell Biology

The Emerging Hallmarks of Cancer Metabolism

Natalya N. Pavlova et al.

CELL METABOLISM (2016)

Article Biotechnology & Applied Microbiology

Comprehensive analyses of tumor immunity: implications for cancer immunotherapy

Bo Li et al.

GENOME BIOLOGY (2016)

Article Biochemistry & Molecular Biology

Extracellular Metabolic Energetics Can Promote Cancer Progression

Jia Min Loo et al.

Article Biochemical Research Methods

Robust enumeration of cell subsets from tissue expression profiles

Aaron M. Newman et al.

NATURE METHODS (2015)

Review Biotechnology & Applied Microbiology

Combination cancer immunotherapy and new immunomodulatory targets

Kathleen M. Mahoney et al.

NATURE REVIEWS DRUG DISCOVERY (2015)

Review Genetics & Heredity

Diagnostic and prognostic epigenetic biomarkers in cancer

Pedro Costa-Pinheiro et al.

EPIGENOMICS (2015)

Article Multidisciplinary Sciences

Inferring tumour purity and stromal and immune cell admixture from expression data

Kosuke Yoshihara et al.

NATURE COMMUNICATIONS (2013)

Article Biochemical Research Methods

NIH Image to ImageJ: 25 years of image analysis

Caroline A. Schneider et al.

NATURE METHODS (2012)

Review Cell Biology

The biology of cancer: Metabolic reprogramming fuels cell growth and proliferation

Ralph J. DeBerardinis et al.

CELL METABOLISM (2008)